AGAPE ATP
ATPC
2 hedge funds and large institutions have $84.6K invested in AGAPE ATP in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
70% more capital invested
Capital invested by funds: $49.8K → $84.6K (+$34.8K)
0.02% more ownership
Funds ownership: 0.01% → 0.04% (+0.02%)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$71.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $81.9K | +$71.8K | +937 | +208% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $2.64K | -$1.07K | -14 | -24% |
|
ATPC Hedge Fund Activity: Q4 2024 in Review
2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in AGAPE ATP (ATPC) for Q4 2024, worth a combined $84.6K — up 70% from $49.8K a quarter earlier.
Fund positioning in ATPC was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $71.8K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.07K.
- 2 institutional investors held AGAPE ATP (ATPC) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $84.6K of AGAPE ATP stock for Q4 2024, up 70% quarter-over-quarter.
- 0 funds opened new AGAPE ATP positions in Q4 2024 and 0 closed out.
- The largest AGAPE ATP buyer in Q4 2024 was UBS Group, an estimated $71.8K added.
- The largest AGAPE ATP seller in Q4 2024 was Tower Research Capital (TRC), an estimated $1.07K sold.
Based on aggregated 13F filings for Q4 2024.